Generation of ΔF508-CFTR T84 cell lines by CRISPR/Cas9-mediated genome editing

被引:8
作者
Chung, Woo Young [1 ,2 ]
Song, Myungjae [3 ]
Park, Jinhong [4 ]
Namkung, Wan [4 ]
Lee, Jinu [4 ]
Kim, Hyongbum [1 ,2 ]
Lee, Min Goo [1 ,2 ]
Kim, Joo Young [1 ,2 ]
机构
[1] Yonsei Univ, Dept Pharmacol, Coll Med, Seoul 120752, South Korea
[2] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Coll Med, Seoul 120752, South Korea
[3] Hanyang Univ, Coll Med, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea
[4] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Inchon 406840, South Korea
基金
新加坡国家研究基金会;
关键词
CRISPR/Cas9; Delta F508-CFTR; Epithelial cell; Genome editing; T84 cell line; TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEASE-INDUCED MUTATIONS; DEPENDENT HCO3-TRANSPORT; CYSTIC-FIBROSIS; CFTR; ENRICHMENT; MECHANISM; MEMBRANE; SYSTEM; ASSAY;
D O I
10.1007/s10529-016-2190-4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objectives: To provide a simple method to make a stable Delta F508-CFTR-expressing T84 cell line that can be used as an efficient screening model system for Delta F508-CFTR rescue. Results: CFTR knockout cell lines were generated by Cas9 with a single-guide RNA (sgRNA) targeting exon 1 of the CFTR genome, which produced indels that abolished CFTR protein expressions. Next, stable Delta F508-CFTR expression was achieved by genome integration of Delta F508-CFTR via the lentivirus infection system. Finally, we showed functional rescue of Delta F508-CFTR not only by growing the cells at a low temperature, but also incubating with VX-809, a Delta F508-CFTR corrector, in the established T84 cells expressing Delta F508-CFTR. Conclusions: This cell system provides an appropriate screening platform for rescue of Delta F508-CFTR, especially related to protein folding, escaped from endoplasmic-reticulum-associated protein degradation, and membrane transport.
引用
收藏
页码:2023 / 2034
页数:12
相关论文
共 32 条
[1]  
Ain QU, 2014, J CONTROL RELEASE, V205, P120
[2]   Cystic Fibrosis Transmembrane Conductance Regulator Modulators for Personalized Drug Treatment of Cystic Fibrosis Progress to Date [J].
Becq, Frederic .
DRUGS, 2010, 70 (03) :241-259
[3]   T84 CELLS - ANION SELECTIVITY DEMONSTRATES EXPRESSION OF CL- CONDUCTANCE AFFECTED IN CYSTIC-FIBROSIS [J].
BELL, CL ;
QUINTON, PM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (03) :C555-C562
[4]   Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease [J].
Cho, Seung Woo ;
Kim, Sojung ;
Kim, Jong Min ;
Kim, Jin-Soo .
NATURE BIOTECHNOLOGY, 2013, 31 (03) :230-232
[5]   Aberrant CFTR-dependent HCO3- transport in mutations associated with cystic fibrosis [J].
Choi, JY ;
Muallem, D ;
Kiselyov, K ;
Lee, MG ;
Thomas, PJ ;
Muallem, S .
NATURE, 2001, 410 (6824) :94-97
[6]   Multiplex Genome Engineering Using CRISPR/Cas Systems [J].
Cong, Le ;
Ran, F. Ann ;
Cox, David ;
Lin, Shuailiang ;
Barretto, Robert ;
Habib, Naomi ;
Hsu, Patrick D. ;
Wu, Xuebing ;
Jiang, Wenyan ;
Marraffini, Luciano A. ;
Zhang, Feng .
SCIENCE, 2013, 339 (6121) :819-823
[7]   PROCESSING OF MUTANT CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR IS TEMPERATURE-SENSITIVE [J].
DENNING, GM ;
ANDERSON, MP ;
AMARA, JF ;
MARSHALL, J ;
SMITH, AE ;
WELSH, MJ .
NATURE, 1992, 358 (6389) :761-764
[8]   Rescue of ΔF508-CFTR Trafficking via a GRASP-Dependent Unconventional Secretion Pathway [J].
Gee, Heon Yung ;
Noh, Shin Hye ;
Tang, Bor Luen ;
Kim, Kyung Hwan ;
Lee, Min Goo .
CELL, 2011, 146 (05) :746-760
[9]  
Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15
[10]  
Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/nmeth.1733, 10.1038/NMETH.1733]